Our findings reveal that OLFML1 expression is regulated by insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), a well-known RNA-binding protein implicated in cancer progression. This evidence concerns the gene IGF2BP3 and cancer.